Clinical Trials Browser

Unknown × Triple Negative Breast Neoplasms × niraparib × Clear all

NCT05461690 2022-07-18

Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency

Phase 2 Unknown

Triple Negative Breast Neoplasms